Report on orphan drugs in Europe suggests changing pharma incentives

Report on orphan drugs in Europe suggests changing pharma incentives

More reads

• ‘We’re going to keep going’: A new clinical trial for ALS gives patients hope. (Boston Globe)
• A long-awaited report on orphan drugs in Europe suggests incentives to pharma need change. (STAT)
• 21 biotech startups that are set to take off, according to top VCs. (Business Insider)
• The curious story of Kodak’s pivot to pharma. (Financial Times)